Your browser doesn't support javascript.
loading
Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience.
Aygen, Bilgehan; Demirtürk, Nese; Yildiz, Orhan; Çelen, Mustafa Kemal; Çelik, Ilhami; Barut, Sener; Ural, Onur; Batirel, Ayse; Mistik, Resit; Simsek, Funda; Asan, Ali; Ersöz, Gülden; Türker, Nesrin; Bilgin, Hüseyin; Kinikli, Sami; Karakeçili, Faruk; Zararsiz, Gökmen; Turkish Society Of Clinical Microbiology And Infectious Diseases, The Study Group For Viral Hepatitis Of The.
Afiliação
  • Aygen B; Department of Infectious Diseases and Clinical Microbiology, Erciyes University School of Medicine, Kayseri, Turkey.
  • Demirtürk N; Department of Infectious Diseases and Clinical Microbiology, Afyon Kocatepe University School of Medicine, Afyonkarahisar, Turkey.
  • Yildiz O; Department of Infectious Diseases and Clinical Microbiology, Erciyes University School of Medicine, Kayseri, Turkey.
  • Çelen MK; Department of Infectious Diseases and Clinical Microbiology, Dicle University School of Medicine, Diyarbakir, Turkey.
  • Çelik I; Department of Infectious Diseases and Clinical Microbiology, Saglik Bilimleri University Kayseri Training and Research Hospital, Kayseri, Turkey.
  • Barut S; Department of Infectious Diseases and Clinical Microbiology, Gaziosmanpasa University School of Medicine, Tokat, Turkey.
  • Ural O; Department of Infectious Diseases and Clinical Microbiology, Selçuk University School of Medicine, Konya, Turkey.
  • Batirel A; Department of Infectious Diseases and Clinical Microbiology, Saglik Bilimleri University Kartal Dr. Lütfü Kirdar Training and Research Hospital, Istanbul, Turkey.
  • Mistik R; Department of Infectious Diseases and Clinical Microbiology, Uludag University School of Medicine, Bursa, Turkey.
  • Simsek F; Department of Infectious Diseases and Clinical Microbiology, Okmeydani Training and Research Hospital, Istanbul, Turkey.
  • Asan A; Department of Infectious Diseases and Clinical Microbiology, Saglik Bilimleri University Yüksek Ihtisas Training and Research Hospital, Bursa, Turkey.
  • Ersöz G; Department of Infectious Diseases and Clinical Microbiology, Mersin University School of Medicine, Mersin, Turkey.
  • Türker N; Department of Infectious Diseases and Clinical Microbiology, Katip Çelebi University Atatürk Training and Research Hospital, Izmir, Turkey.
  • Bilgin H; Department of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, Istanbul, Turkey.
  • Kinikli S; Department of Infectious Diseases and Clinical Microbiology, Ankara Training and Research Hospital, Ankara, Turkey.
  • Karakeçili F; Department of Infectious Diseases and Clinical Microbiology, Erzincan University School of Medicine, Erzincan, Turkey.
  • Zararsiz G; Department of Biostatistics, Erciyes University School of Medicine, Kayseri, Turkey.
Turk J Gastroenterol ; 31(4): 305-317, 2020 04.
Article em En | MEDLINE | ID: mdl-32412901
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Ribavirina / Sulfonamidas / Uracila / Hepacivirus / Hepatite C Crônica / 2-Naftilamina Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Ribavirina / Sulfonamidas / Uracila / Hepacivirus / Hepatite C Crônica / 2-Naftilamina Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article